跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Bilirubin
首页
药物
Bilirubin
Bilirubin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
DEVELOPMENT AND USE OF FLUORESCENT PROBES OF UNBOUND BILIRUBIN
EP 2748615 B1
申请人: KLEINFELD ALAN M
优先权: 2011
CN
EP
US
WO
11 件公开
DYE FOR KERATIN FIBERS USING BILIRUBIN OXIDASE AND INDOLE DERIVATIVES
EP 2623093 B1
申请人: AMANO ENZYME INC
优先权: 2011
EP
US
WO
5 件公开
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES COMPRISING PEGYLATED BILIRUBIN
US 20260000600 A1
申请人: BILIX CO LTD
优先权: 2022
CN
EP
US
WO
4 件公开
PHARMACEUTICAL COMPOSITION FOR TREATING, PREVENTING, OR MANAGING BILIRUBIN-INDUCED NEUROLOGICAL DYSFUNCTION, PSYCHIATRIC DISORDERS ASSOCIATED WITH JAUNDICE, OR PSYCHIATRIC DISORDERS CAUSED BY BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE GENE MUTATIONS
EP 4678188 A1
申请人: OHNISHI ARATA
优先权: 2023
CN
EP
WO
3 件公开
NEAR-INFRARED RESPONSIVE BILIRUBIN COMPOSITE NANOPARTICLE-LOADED PERIODONTAL MICRONEEDLE AND PREPARATION METHOD THEREOF
US 20260166149 A1
申请人: STOMATOLOGICAL HOSPITAL OF CHONGQING MEDICAL UNIV
优先权: 2023
CN
US
WO
3 件公开
Bilirubin derivative-based diagnostic and therapeutic ultrasound contrast agent
US 11571486 B2
申请人: BILIX CO LTD
优先权: 2018
CN
US
3 件公开
METHOD FOR SYNTHESIZING BILIRUBIN
US 2024327345 A1
申请人: BILIX CO LTD
优先权: 2021
US
WO
3 件公开
US 20250122154 A1
申请人: BILIX CO LTD
优先权: 2021
US
WO
2 件公开
US 2024239745 A1
申请人: BILIX CO LTD
优先权: 2021
US
WO
2 件公开
COMPOSITION FOR TREATING SKIN PIGMENTATION
US 2013164234 A1
申请人: LONZA WALKERSVILLE INC
优先权: 2012
US
3 件公开
Particles comprising bilirubin derivative and metal
US 11896681 B2
申请人: BILIX CO LTD
优先权: 2017
CN
US
2 件公开
Method for degrading bilirubin in skin
US 10874600 B2
申请人: PROCTER & GAMBLE
优先权: 2018
CN
US
2 件公开
第 1 / 10 页
上一页
下一页
药物
反馈